Country Profile at a Glance

Market Overview

Healthcare Infrastructure

Vietnam has approximately 1,400 public hospitals and over 35,000 communal health stations. The government's Target Programme on Healthcare 2021–2030 commits VND 131 trillion (approx. USD 5.2 billion) to upgrading district and provincial hospitals, with a focus on diagnostics, imaging, and surgical capacity. The private hospital sector is growing at over 15% annually, with major groups like Vinmec, FV Hospital, and Columbia Asia expanding aggressively. Medical tourism from Cambodia, Laos, and Myanmar is also growing, pushing private hospitals to upgrade to international standards.

Key Market Drivers

• Government programme investing USD 5.2B in hospital infrastructure upgrades through 2030
• Rapidly growing private hospital sector driven by health-conscious middle class
• Vietnam's disease burden (TB, cancer, cardiovascular) sustaining demand for diagnostics and treatment devices
• Strong economic growth enabling increased healthcare spending at household and government level
• EU-Vietnam Free Trade Agreement (EVFTA) reducing barriers for quality medical imports
• Medical tourism growth pushing private hospitals toward international-standard equipment

Top Product Categories in Demand

Regulatory Environment

Regulatory Authority & Framework

Medical devices in Vietnam are regulated by the Drug Administration of Vietnam (DAV) under Decree 98/2021/ND-CP. All imported devices must undergo registration or licensing depending on risk classification (Class A through Class D under ASEAN AMDD classification). Class A and B products may follow a Declaration of Conformity route; Class C and D require full registration. CE Mark or ISO 13485 certification significantly supports the registration process. A locally registered importer is mandatory. Registration timelines range from 3 months (Class A) to 18+ months (Class C/D).

Key Registration Requirements

• DAV import license and device registration (class-dependent route)
• ISO 13485 certificate and CE Mark or equivalent recognised certification required
• Appointment of a licensed Vietnamese importer/distributor
• Vietnamese language IFU (Instructions for Use) for Class C and D devices
• Post-market surveillance reporting to DAV
• Import tax: 0–5% for most medical devices; some categories zero-rated under EVFTA

Import & Trade Data

Vietnam imports approximately 90% of medical devices. The dominant suppliers are Japan, South Korea, Germany, and the USA. China has gained significant market share in the mid-range and budget segments. Turkey's current presence is primarily through disposables and basic equipment, but there is significant untapped potential in the mid-range segment where Turkish quality and price proposition is competitive.

Opportunities for Turkish Exporters

• Mid-range diagnostic equipment: district hospitals upgrading from obsolete equipment — Turkish manufacturers offer European quality at 30–40% below German/Japanese pricing
• Disposables at scale: Vietnam's high hospital activity creates substantial demand for Turkish-made disposables across all categories
• Hospital modernisation packages: private hospital groups procuring entire fit-out packages — ideal key account targets for Turkish manufacturers of furniture, lighting, and equipment
• Lab equipment: rapid expansion of private diagnostic laboratories in urban centres demanding haematology, biochemistry, and microbiology analysers
• Dental market: Vietnam has over 6,000 private dental clinics with high demand for chairs, X-ray units, and sterilisers

Challenges & Considerations

• Registration complexity: the DAV registration process for Class C/D devices is lengthy and requires detailed technical documentation; expert regulatory support is essential
• Local partner dependency: distribution without a well-connected local partner is nearly impossible in Vietnam's relationship-driven procurement environment
• Price pressure from China: Chinese suppliers aggressively target Vietnam's public hospital segment; Turkish companies must articulate CE compliance and after-sales service advantages clearly
• Language barrier: all marketing, labelling, and technical documentation may need Vietnamese translation for higher-risk class devices
• Payment terms: public hospital procurement can involve delayed payment cycles; confirm payment terms clearly in contracts

Conclusion

Vietnam offers Turkish medical device exporters a compelling combination of scale, growth, and accessibility. Its receptiveness to CE-certified products, growing private hospital sector, and government infrastructure investment create multiple entry points. Companies that invest in a strong local distribution partner and secure DAV registration early will be positioned to grow with one of Asia's most dynamic healthcare markets.